Current concepts in the management of laryngeal papillomatosis.
A wide variety of methods have been described for the treatment of laryngeal papillomatosis. This attests to the difficulties encountered in controlling this often refractory disease. Recent trends have been directed toward immunotherapy and improved techniques of endoscopic excision. The various treatment modalities are reviewed to provide the reader with updated information and a perspective of the current management of this perplexing disease.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D052688:Bovine papillomavirus 1 / Q000276:immunology; D002118:Calcium / Q000627:therapeutic use; D003452:Cryosurgery; D004564:Electrocoagulation; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use; D007822:Laryngeal Neoplasms / Q000601:surgery / Q000628:therapy*; D007978:Levamisole / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D010212:Papilloma / Q000601:surgery / Q000628:therapy*; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum; D011247:Pregnancy; D013754:Tetracyclines / Q000627:therapeutic use; D014165:Transfer Factor / Q000627:therapeutic use; D014464:Ultrasonic Therapy
D000970:Antineoplastic Agents; D004967:Estrogens; D013754:Tetracyclines; D014165:Transfer Factor; D007978:Levamisole; D007372:Interferons; D008274:Magnesium; D002118:Calcium